Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular weight polyethylene, and thermoplastic elastomers, polyesters, and vulcanizates for use in appliance, automotive, construction, consumer apparel, consumer electronics, electrical, energy storage, filtration equipment, industrial, medical, and telecommunication applications. It also provides acetic acid and anhydride, acetate flakes and tows, butyl acetates, emulsion polymers, ethyl acetates, ethylene vinyl acetate resins and compounds, formaldehydes, redispersible powders, and vinyl acetate monomers for use in adhesives, automotive parts, coatings, consumer goods, external thermal insulation composite systems, films, filtration, flexible packaging, food and beverage, food packaging, inks, lamination, lubricants, paints, paper finishing, pharmaceuticals, plasticizers, plasters and renders, solvents, textiles, and tiling applications. The company offers its products under the Amcel, AOPlus, Ateva, Avicor, Celanese, Celanex, Celanyl, Celcon, Celstran, Celvolit, Clarifoil, Crastin, Dur-O-Set, Dytron, ECOMID, EcoVAE, Elotex, Factor, Flexbond, Forprene, FRIANYL, Fortron, Geolast, GHR, GUR, Hostaform, Hytrel, Laprene, Melinex, MetaLX, Mowilith, MT, Mylar, NILAMID, Nylfor, OmniLon, Pibifor, Pibiter, Polifor, Resyn, Rynite, Santoprene, SlideX, Sofprene, Sofpur, Talcoprene, Tarnoform, Tecnoprene, TufCOR, Tynex, Vamac, VAntage, Vectra, Vinac, Vinamul, VitalDose, Zenite, and Zytel brands. It sells its products directly to customers and through distributors; and original equipment manufacturers and suppliers. Celanese Corporation was founded in 1912 and is headquartered in Irving, Texas.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $9.5B | $267M | $-1.2B | $803M | -28.8% | -7.1% | -24.4% |
| 2024 | $10.3B | $480M | $-1.5B | $531M | -30.1% | -6.0% | -179.4% |
| 2023 | $10.9B | $2.6B | $1.9B | $1.3B | 27.4% | 13.0% | 2.6% |
| 2022 | $9.7B | $2.3B | $1.9B | $1.3B | 33.6% | - | - |
| 2021 | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 9,673 | 10,926 | 10,268 | 9,544 |
| Operating Revenue | - | 9,673 | 10,926 | 10,268 | 9,544 |
| Cost Of Revenue | - | 7,293 | 8,343 | 7,932 | 7,592 |
| Gross Profit | - | 2,380 | 2,583 | 2,336 | 1,952 |
| Operating Expense | - | 998 | 1,387 | 1,322 | 1,188 |
| Research And Development | - | 112 | 146 | 130 | 125 |
| Selling General And Administration | - | 824 | 1,077 | 1,033 | 899 |
| Total Expenses | - | 8,291 | 9,730 | 9,254 | 8,780 |
| Operating Income | - | 1,382 | 1,196 | 1,014 | 764 |
| Total Operating Income As Reported | - | 1,378 | 1,665 | -720 | -786 |
| EBITDA | - | 2,304 | 2,620 | 480 | 267 |
| Normalized EBITDA | - | 2,175 | 2,025 | 2,086 | 1,695 |
| EBIT | - | 1,826 | 1,881 | -343 | -519 |
| Interest Income | - | 69 | 39 | 33 | 24 |
| Interest Expense | - | 405 | 720 | 676 | 701 |
| Net Interest Income | - | -336 | -688 | -643 | -745 |
| Other Non Operating Income Expenses | - | 26 | -44 | 20 | 62 |
| Other Income Expense | - | 375 | 653 | -1,390 | -1,239 |
| Interest Income Non Operating | - | 69 | 39 | 33 | 24 |
| Interest Expense Non Operating | - | 405 | 720 | 676 | 701 |
| Net Non Operating Interest Income Expense | - | -336 | -688 | -643 | -745 |
| Pretax Income | - | 1,421 | 1,161 | -1,019 | -1,220 |
| Tax Provision | - | -489 | -795 | 507 | -90 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 27.09 | 124.95 | -337.26 | -105.67 |
| Net Income Continuous Operations | - | 1,910 | 1,956 | -1,526 | -1,130 |
| Net Income From Continuing And Discontinued Operation | - | 1,894 | 1,943 | -1,542 | -1,165 |
| Net Income From Continuing Operation Net Minority Interest | - | 1,902 | 1,952 | -1,534 | -1,144 |
| Net Income | - | 1,894 | 1,943 | -1,542 | -1,165 |
| Net Income Common Stockholders | - | 1,894 | 1,943 | -1,542 | -1,165 |
| Net Income Including Noncontrolling Interests | - | 1,902 | 1,947 | -1,534 | -1,151 |
| Normalized Income | - | 1,800.09 | 1,481.95 | -265.26 | 178.33 |
| Diluted NI Availto Com Stockholders | - | 1,894 | 1,943 | -1,542 | -1,165 |
| Basic Average Shares | - | 108.40 | 108.80 | 109.30 | 109.50 |
| Diluted Average Shares | - | 109.20 | 109.40 | 109.30 | 109.50 |
| Reconciled Depreciation | - | 478 | 739 | 823 | 786 |
| Reconciled Cost Of Revenue | - | 6,877 | 7,768 | 7,268 | 6,970 |
| Total Unusual Items | - | 129 | 595 | -1,606 | -1,428 |
| Total Unusual Items Excluding Goodwill | - | 129 | 595 | -1,606 | -1,428 |
| Minority Interests | - | -8 | -4 | -8 | -14 |
| Net Income Discontinuous Operations | - | -8 | -9 | -8 | -21 |
| Special Income Charges | - | -3 | 437 | -1,758 | -1,586 |
| Gain On Sale Of Business | - | 5 | 505 | -14 | -5 |
| Impairment Of Capital Assets | - | 14 | 15 | 1,639 | 1,513 |
| Restructuring And Mergern Acquisition | - | -6 | 53 | 105 | 68 |
| Gain On Sale Of Security | - | 132 | 158 | 152 | 158 |
| Depreciation Amortization Depletion Income Statement | - | 62 | 164 | 159 | 164 |
| Depreciation And Amortization In Income Statement | - | 62 | 164 | 159 | 164 |
| Gain On Sale Of Ppe | 10 | 12 | -1 | - | - |
| Total Other Finance Cost | 9 | - | 7 | - | 68 |
| Earnings From Equity Interest | - | 220 | 102 | 196 | 127 |
| Amortization | - | 62 | 164 | 159 | 164 |
| Amortization Of Intangibles Income Statement | - | 62 | 164 | 159 | 164 |
Basic Materials sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Celanese Corporationthis co. | CE | $5.9B | -5.08 | 1.46 | -28.8% | 65.88 |
| Eastman Chemical Company | EMN | $8.3B | 17.47 | 1.39 | 8.0% | 9.62 |
| The Mosaic Company | MOS | $7.3B | 13.46 | 0.60 | 4.5% | 4.90 |
| Century Aluminum Company | CENX | $6.6B | 157.29 | 8.16 | 5.2% | 49.15 |
| Warrior Met Coal, Inc. | HCC | $5.6B | 98.13 |
| - |
| - |
| - |
| - |
| - |
| 2.61 |
| 2.7% |
| 22.01 |
| Balchem Corporation | BCPC | $5.1B | 32.79 | 4.04 | 12.3% | 20.33 |
| Sensient Technologies Corporation | SXT | $4.8B | 35.70 | 4.02 | 11.3% | 20.41 |
| Materion Corporation | MTRN | $4.7B | 63.23 | 5.02 | 7.9% | 28.96 |
| H.B. Fuller Company | FUL | $3.3B | 21.64 | 1.64 | 7.6% | 9.98 |
| Peer Median | - | 34.25 | 3.32 | 7.8% | 20.37 | |